Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APX001 Safety and PK in Healthy Subjects
NCT02956499Phase 1Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- May 2016
- Primary completion
- Jul 2017
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fosmanogepix in fungal infection, sponsored by Basilea Pharmaceutica. Started May 2016; status: completed.
02
Drugs
fosmanogepix
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT02956499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956499.